Nasdaq Listing
-
Financial
BioRestorative Therapies Regains Compliance with Nasdaq Listing Rule 5250(c)(1); Reports First Quarter 2024 Financial Results
– Significant YoY improvement in operating performance – – Ends Q1-2024 with $16.4 million cash, cash equivalents, and marketable securities –…
Read More » -
Financial
Amedica Receives Positive Nasdaq Listing Decision
SALT LAKE CITY, Oct. 17, 2017 (GLOBE NEWSWIRE) — Amedica Corporation (Nasdaq: AMDA) (the “Company”), an innovative biomaterial company that…
Read More »